Teresa Quattrin, EASD 2020 – What Does the Future Hold for Paediatric Type 1 Diabetes Patients?

We caught up with EASD President Stefano Del Prato (University of Pisa and University Hospital of Pisa) ahead of this year’s virtual meeting to hear about the key topics being discussed. Disclosures: Sterfano Del Prato has received research support from AstraZeneca, Boehringer Ingelheim, Merck Sharp & Dohme and served on the advisory board for Abbott, […]

We were delighted to speak with Mikael Rydén (Honorary Secretary EASD 2020 and Karolinska Institutet, Stockholm, Sweden) about the ongoing research in his group around human white adipocyte cells. Speaker Disclosures: Mikael Rydén has nothing to disclose in relation to this video. Support: Interview and filming supported by Touch Medical Media. Filmed as a highlight […]

We were delighted to speak with Teresa Quattrin (University at Buffalo, Oishei Children’s Hospital) at virtual EASD 2020 to talk about the treatment landscape for children with type 1 diabetes and what the future holds. Speaker Disclosures: Tersea Quattrin discloses the following: Consultant to Janssen Research & Development Clinical Trial, Principal Investigator at the Buffalo […]